M. Alexander-Curtis, “Safety, tolerability and pharmacokinetic profile of recombinant human tissue kallikrein, DM199, after intravenous and subcutaneous administration in healthy volunteers”, Int J Clin Trials, vol. 4, no. 4, pp. 139–146, Oct. 2017.